-
UK police brace far-right rally and counter demonstration
-
Israel says Hamas armed wing chief killed in Gaza strike
-
Cantona on the couch: footballer explores 'demons' in raw new film
-
Lewandowski to leave Barca with 'mission complete'
-
Pope Leo to visit France September 25-28
-
Trump, Nigeria claim killing of senior IS leader
-
Acosta takes pole, Bezzecchi crashes in Catalan MotoGP qualifying
-
Arbeloa 'happy' if Mourinho back at Real Madrid next season
-
Fiery Finns, Australian star favourites at boycotted Eurovision final
-
Haaland to play marauding Viking in new animated film
-
Lyles excited to race 'good kid' Gout over 150m
-
'Parasite' director Bong says making animated film to 'surpass' Miyazaki
-
World Cup fever gets tail-wagging twist as Singapore kits out pets
-
France-born Bouaddi approved to play for Morocco before World Cup
-
South Korea coach backs Son to shine at his fourth World Cup
-
Putin to visit China May 19-20, days after Trump trip
-
Eurovision gears up for boycotted final, with fiery Finns favourites
-
Son Heung-min to lead South Korea squad at his fourth World Cup
-
Pretty in pink: Dallas World Cup venue chasing perfect pitch
-
Wordle heads to primetime as media seek puzzle reinvention
-
Eurovision: the grand final running order
-
McIlroy, back in PGA hunt, blames bad setup for lead logjam
-
Kubo vows to lead Japan at World Cup with Mitoma out
-
McNealy and Smalley share PGA lead at difficult Aronimink
-
Drake drops three albums at once
-
Boeing confirms China commitment to buy 200 aircraft
-
Knicks forward Anunoby trains as NBA Eastern Conference finals loom
-
American McNealy grabs PGA lead at difficult Aronimink
-
Substitute 'keeper sends Saint-Etienne into promotion play-off
-
Sinner's bid to reach Italian Open final held up by Roman rain
-
Aston Villa humble Liverpool to secure Champions League qualification
-
US says Iran-backed militia commander planned Jewish site attacks
-
Bolivia unrest continues despite government deal with miners
-
Scheffler slams 'absurd' PGA pin locations
-
New deadly Ebola outbreak hits DR Congo, 1 dead in Uganda
-
Democrats accuse Trump of stock trade corruption
-
'Beyond the Oscar': Travolta gets surprise Cannes prize
-
Israel, Lebanon say extending ceasefire despite new strikes
-
Potgieter grabs early PGA lead at difficult Aronimink
-
Prosecutors seek death penalty for US man charged with killing Israeli embassy staffers
-
Judge declares mistrial in Weinstein sex assault case
-
Canada takes key step towards new oil pipeline
-
Iranian filmmaker Farhadi condemns Middle East war, protest massacres
-
'Better than the Oscar': John Travolta gets surprise Cannes prize
-
Marsh muscle motors Lucknow to victory over Chennai
-
Judge declares mistrial in Weinstein case as jury fails to reach verdict
-
Eurovision finalists tune up as boycotting Spain digs in
-
Indonesia's first giant panda is set to charm the public
-
Cheer and tears as African refugee rap film 'Congo Boy' charms Cannes
-
Norwegian Ruud rolls into Italian Open final, Sinner set for Medvedev clash
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
O.Bulka--BTB